4
Changes in Ownership
HAEMONETICS CORP Filed Acc 0001127602-20-014068
EVP, Chief Technology Officer acquired 2,181 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lingamneni Anila EVP, Chief Technology Officer | 2020-04-15 | Grant or award | +2,181 | 2,181 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lingamneni Anila EVP, Chief Technology Officer | 2020-04-15 | Grant or award · Non-qualified Stock Option (Right to Buy) | +7,509 | 7,509 | D: show line 2 in the form |
Loading xslF345X03/form4.xml…